Alobaid Thamer, O'Connell Matthew D L, Karalliedde Janaka, Ayis Salma
School of Life Course and Population Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.
Faculty of Life Science & Medicine, King's College London, Consultant in Diabetes, Endocrinology and Internal Medicine, Guy's, and St Thomas' Hospital London, London, UK.
BMC Nephrol. 2025 Jul 1;26(1):298. doi: 10.1186/s12882-025-04235-8.
People with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD) exhibit diverse patterns of kidney function decline. However, there is limited evidence on the impact of ethnicity and diabetic retinopathy on the rate of estimated glomerular filtration rate (eGFR) decline and the progression of CKD.
We analysed 14,489 people with T2DM and baseline eGFR ≥ 45 ml/min/1.73 m² attending outpatient clinics at south London hospitals from 2004 to 2018. The ethnically diverse cohort included 45% White, 37.8% Black, 9.1% Asian, 2.7% Mixed, and 5.2% Other ethnicities. The latent class analysis approach, Group Based Trajectory Model (GBTM) was used to identify eGFR trajectories, and multinomial logistic models assessed CKD progression to stages 4 and 5 among those with faster eGFR decline (≥ 1.92 ml/min/year).
Four eGFR trajectories were identified from each ethnic group. Those with the fastest decline (n = 2,531) were older, had higher urine albumin-to-creatinine ratio (ACR), and lower baseline eGFR. Of this group, 368 (14.53%) progressed to stage 5 CKD. Relative risk ratios (95% CI) of progression compared to White individuals were 1.64 (1.22-2.21) for Black, 2.39 (1.57-3.64) for Asian, 1.97 (1.11-3.50) for Mixed, and 3.72 (2.11-6.57) for other ethnicities. Diabetic retinopathy at baseline was present in 17.58% of this group, and linked to faster CKD progression, particularly among Black individuals.
Non-White ethnicities experience faster CKD progression, with diabetic retinopathy contributing significantly, especially in Black individuals. These findings highlight the need for tailored strategies of prevention and intervention to address disparities in CKD outcomes.
2型糖尿病(T2DM)和慢性肾脏病(CKD)患者的肾功能下降模式各不相同。然而,关于种族和糖尿病视网膜病变对估计肾小球滤过率(eGFR)下降速率和CKD进展的影响,证据有限。
我们分析了2004年至2018年在伦敦南部医院门诊就诊的14489例T2DM患者,其基线eGFR≥45ml/min/1.73m²。这个种族多样化的队列包括45%的白人、37.8%的黑人、9.1%的亚洲人、2.7%的混血儿和5.2%的其他种族。采用潜在类别分析方法,即基于群体的轨迹模型(GBTM)来识别eGFR轨迹,并使用多项逻辑模型评估eGFR下降较快(≥1.92ml/min/年)的患者中CKD进展至4期和5期的情况。
每个种族群体均识别出4种eGFR轨迹。下降最快的患者(n = 2531)年龄较大,尿白蛋白肌酐比值(ACR)较高,基线eGFR较低。在这一组中,368例(14.53%)进展至CKD 5期。与白人个体相比,黑人进展的相对风险比(95%CI)为1.64(1.22 - 2.21),亚洲人为2.39(1.57 - 3.64),混血儿为1.97(1.11 - 3.50),其他种族为3.72(2.11 - 6.57)。该组中17.58%的患者基线时存在糖尿病视网膜病变,且与较快的CKD进展相关,尤其是在黑人个体中。
非白人种族的CKD进展较快,糖尿病视网膜病变起了重要作用,尤其是在黑人个体中。这些发现凸显了需要制定针对性的预防和干预策略,以解决CKD结局方面的差异。